Futura Medical plc (LON:FUM – Get Free Report)’s share price shot up 12.4% on Monday . The company traded as high as GBX 38.70 ($0.51) and last traded at GBX 37.65 ($0.50). 1,535,442 shares traded hands during mid-day trading, an increase of 153% from the average session volume of 606,661 shares. The stock had previously closed at GBX 33.50 ($0.44).
Futura Medical Price Performance
The stock has a market cap of £113.65 million, a price-to-earnings ratio of -1,675.00 and a beta of 1.22. The business’s 50-day simple moving average is GBX 35.14 and its two-hundred day simple moving average is GBX 37.61.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Further Reading
- Five stocks we like better than Futura Medical
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- CD Calculator: Certificate of Deposit Calculator
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 8/26 – 8/30
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.